Esperance Pharmaceuticals

About:

Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.

Website: https://esperancepharma.com/

Top Investors: Sanofi, Advantage Capital, Research Corporation Technologies, Louisiana Technology Innovation Fund, Louisiana Funds

Description:

Esperance Pharmaceuticals is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell's surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs.